Literature DB >> 15882291

Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France.

Ylana Chalem1, Jean-Philippe Ryckelynck, Philippe Tuppin, Christian Verger, Sylvie Chauvé, Denis Glotz.   

Abstract

BACKGROUND: Although peritoneal dialysis (PD) is recognized as one of the methods of treatment of end-stage renal disease (ESRD), there have been recurrent concerns about the access of patients treated by this modality to kidney transplantation (KTx), as well as reports showing increased complications of KTx in such patients, such as graft thrombosis and infections.
METHODS: The aim of this study was to provide a comprehensive view of the impact on transplantation of pretransplant modality of treatment of ESRD using a multivariate analysis of the French database. From 1997 to 2000, after exclusion of pediatric patients, multiple transplantations, and living donors, 6420 were patients registered on the waiting list, and 3464 were transplanted.
RESULTS: Using a Cox proportional hazard analysis, we found a shorter waiting time for PD patients (RR 0.71, P < 0.0001), which became equivalent to hemodialysis (HD) patients when taking into account the transplant center as a variable (RR 1.0, P= 0.95). Concerning graft survival, only preemptive transplantation had a significant impact, being associated to a decreased risk of graft failure (RR 0.46, P= 0.005). Conclusion. Our study supports the concept that the choice of any pretransplant dialysis modality does not influence waiting time for transplant or the results of transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 15882291     DOI: 10.1111/j.1523-1755.2005.00353.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Should peritoneal dialysis catheters be removed at the time of kidney transplantation?

Authors:  Jeff Warren; Emily Jones; Alp Sener; Martin Drage; Ali Taqi; Sian Griffin; Christopher Watson; Patrick P W Luke
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

2.  Effect of center practices on the choice of the first dialysis modality for children and young adults.

Authors:  Julien Hogan; Bruno Ranchin; Marc Fila; Jérome Harambat; Saoussen Krid; Isabelle Vrillon; Gwenaelle Roussey; Michel Fischbach; Cécile Couchoud
Journal:  Pediatr Nephrol       Date:  2016-11-14       Impact factor: 3.714

3.  Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study.

Authors:  Hong Jae Jeon; Hong Jin Bae; Young Rok Ham; Dae Eun Choi; Ki Ryang Na; Moon-Sang Ahn; Kang Wook Lee
Journal:  Kidney Res Clin Pract       Date:  2019-03-31

Review 4.  Home dialysis as a first option: a new paradigm.

Authors:  Dimitrios G Oreopoulos; Elias Thodis; Ploumis Passadakis; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2009-05-09       Impact factor: 2.370

5.  [Peritoneal dialysis in patients under twenty years: experience in a Moroccan university hospital].

Authors:  Intissar Haddiya; Hakima Rhou; Fatima Ezaitouni; Naima Ouzeddoun; Rabia Bayahia; Loubna Benamar
Journal:  Pan Afr Med J       Date:  2012-06-23

6.  In Peritoneal Dialysis, Is There Sufficient Evidence to Make "PD First" Therapy?

Authors:  Pranav Dalal; Harbaksh Sangha; Kunal Chaudhary
Journal:  Int J Nephrol       Date:  2011-06-16

7.  Factors influencing survival after kidney transplant failure.

Authors:  Jennifer A McCaughan; Christopher C Patterson; Alexander P Maxwell; Aisling E Courtney
Journal:  Transplant Res       Date:  2014-09-24

8.  The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.

Authors:  Robin W M Vernooij; Way Law; Sanne A E Peters; Bernard Canaud; Andrew Davenport; Muriel P C Grooteman; Fatih Kircelli; Francesco Locatelli; Francisco Maduell; Marion Morena; Menso J Nubé; Ercan Ok; Ferran Torres; Mark Woodward; Peter J Blankestijn; Michiel L Bots
Journal:  BMC Nephrol       Date:  2021-02-25       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.